Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Nov 30, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.00%5.86B | 10.07%1.51B | 14.37%1.41B | 25.47%5.37B | 19.72%1.52B | 27.49%1.24B | 27.13%1.37B | 29.20%1.23B | 33.99%4.28B | 26.89%1.27B |
| Cost of revenue | 8.44%1.43B | 7.54%359.7M | 12.42%343.18M | 16.54%1.32B | 13.36%391.25M | 20.32%286.99M | 14.16%334.48M | 20.05%305.26M | 12.10%1.13B | 1.22%345.12M |
| Gross profit | 9.19%4.43B | 10.89%1.15B | 15.01%1.07B | 28.68%4.05B | 22.09%1.13B | 29.81%957.36M | 31.95%1.04B | 32.52%927.31M | 44.09%3.15B | 40.12%927.35M |
| Operating expense | 10.64%4.17B | 10.51%1.05B | 5.76%942.22M | 6.63%3.77B | -3.29%979.3M | 7.46%952.62M | 13.57%948.15M | 11.02%890.9M | 20.74%3.54B | 33.00%1.01B |
| Operating profit | -10.14%254.9M | 14.92%102.97M | 241.39%124.29M | 173.60%283.65M | 279.31%152.91M | 103.18%4.74M | 285.01%89.6M | 135.45%36.41M | 48.07%-385.38M | 14.36%-85.28M |
| Net non-operating interest income (expenses) | 28.77%-18.87M | 42.36%-4.19M | 12.77%-4.13M | -45.54%-26.49M | -40.83%-7.99M | -53.35%-6.5M | -50.56%-7.27M | -36.71%-4.73M | 29.69%-18.2M | 11.65%-5.68M |
| Non-operating interest income | -23.66%3.89M | -10.54%883K | -25.33%1.83M | 3.70%5.1M | 280.00%19K | 4.31%1.64M | -5.10%987K | 6.67%2.45M | 149.29%4.92M | 600.00%5K |
| Non-operating interest expense | -27.95%22.76M | -38.55%5.07M | -17.05%5.95M | 36.64%31.59M | 41.04%8.01M | 40.06%8.14M | 40.70%8.26M | 24.73%7.18M | -17.02%23.12M | -11.55%5.68M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 205K | 0 | 0 | 0 | 0 | ||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 5,928.73%85.62M | 101.88M | 0 | 92.76%-1.47M | 95.17%-955K | 0 | 0 | 34.10%-514K | -101.46%-20.29M | -101.42%-19.79M |
| Less:Other special charges | -5,928.73%-85.62M | ---- | ---- | -92.76%1.47M | -95.17%955K | --0 | --0 | -34.10%514K | 101.46%20.29M | 101.42%19.79M |
| Other non-operating income (expenses) | 3,749.18%4.45M | -320.00%-42K | 24,073.68%4.56M | -100.16%-122K | -101.43%-60K | 98.87%-33K | -100.02%-10K | -100.07%-19K | -73.91%77.11M | -97.02%4.19M |
| Income before tax | 27.50%326.11M | 143.10%200.62M | 300.46%124.72M | 173.76%255.78M | 235.05%143.9M | 98.84%-1.79M | 1,344.89%82.52M | 139.30%31.15M | -139.95%-346.75M | -107.48%-106.56M |
| Income tax | 116.50%22.7M | -8,425.49%-50.95M | -2,082.16%-12.11M | -5,722.68%-137.59M | -22,881.37%-139.42M | 0.00%612K | 0.00%612K | 0.00%611K | 100.54%2.45M | 100.13%612K |
| Net income | -22.87%303.42M | 207.12%251.57M | 348.15%136.83M | 212.65%393.36M | 364.37%283.33M | 98.45%-2.41M | 1,231.07%81.91M | 138.23%30.53M | -126.45%-349.2M | -105.71%-107.17M |
| Net income continuous operations | -22.87%303.42M | 207.12%251.57M | 348.14%136.83M | 212.65%393.36M | 364.37%283.32M | 98.45%-2.41M | 1,231.22%81.91M | 138.23%30.53M | -126.45%-349.2M | -105.71%-107.17M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -22.87%303.42M | 207.12%251.57M | 348.15%136.83M | 212.65%393.36M | 364.37%283.33M | 98.45%-2.41M | 1,231.07%81.91M | 138.23%30.53M | -126.45%-349.2M | -105.71%-107.17M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -22.87%303.42M | 207.12%251.57M | 348.15%136.83M | 212.65%393.36M | 364.37%283.33M | 98.45%-2.41M | 1,231.07%81.91M | 138.23%30.53M | -126.45%-349.2M | -105.71%-107.17M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -22.85%256.95 | 207.15%213.04 | 348.24%115.87 | 212.65%333.07 | 364.38%239.9 | 98.44%-2.04 | 1,231.48%69.36 | 138.23%25.85 | -126.44%-295.66 | -105.70%-90.74 |
| Diluted earnings per share | -22.85%256.95 | 207.18%213.04 | 348.24%115.87 | 212.65%333.07 | 364.38%239.9 | 98.44%-2.04 | 1,231.10%69.3538 | 138.23%25.85 | -126.44%-295.66 | -105.71%-90.74 |
| Dividend per share | 0.00%25 | 0 | 0 | 25 | 25 | 0 | 0 | 0 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |